Dermata Therapeutics Inc (DRMA) — Defensive Interval Ratio
Dermata Therapeutics Inc (DRMA) has a Defensive Interval Ratio of 2 days as of December 2023. Defensive assets of $8.36K (cash $-, short-term investments $-, receivables $8.36K) cover 2 days of daily cash needs of $4.45K/day.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Dermata Therapeutics Inc Defensive Interval Ratio (2022–2024)
This chart shows how Dermata Therapeutics Inc's Defensive Interval Ratio has evolved across 3 annual periods from 2022 to 2024. As of December 2023, the ratio stands at 2 days, meaning defensive assets of $8.36K can fund 2 days of operations without new revenue. For the complete balance sheet picture, see DRMA current and non-current assets.
Annual Defensive Interval Ratio for Dermata Therapeutics Inc (2022–2024)
The table below presents the year-by-year Defensive Interval Ratio for Dermata Therapeutics Inc from 2022 to 2024, covering 3 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. See working capital position of Dermata Therapeutics Inc to evaluate short-term liquidity relative to the company's equity base.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2024 | 584359 days | $3.16 Billion | $5.40K/day | $- | $3.16 Billion | ▲ +584357 days |
| 2023 | 2 days | $8.36K | $4.45K/day | $- | $- | ▼ -3 days |
| 2022 | 5 days | $12.60K | $2.53K/day | $- | $- | — |